BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35938024)

  • 1. Pan-cancer analysis of the FAM83 family and its association with prognosis and tumor microenvironment.
    Yuan S; Huang Z; Qian X; Wang Y; Fang C; Chen R; Zhang X; Xiao Z; Wang Q; Yu B; Li Y
    Front Genet; 2022; 13():919559. PubMed ID: 35938024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach.
    Snijders AM; Lee SY; Hang B; Hao W; Bissell MJ; Mao JH
    Mol Oncol; 2017 Feb; 11(2):167-179. PubMed ID: 28078827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer.
    Zhang T; Lai S; Cai Y; Huang Z; Li Y; Chen S; Zhang Z; Ye Z; Lai X; Zhai E; Cai S; Chen J
    Front Cell Dev Biol; 2021; 9():719613. PubMed ID: 34869310
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer.
    Jin Y; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
    World J Surg Oncol; 2022 Jun; 20(1):172. PubMed ID: 35650627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.
    Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B
    Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMX family genes and their association with prognosis, immune infiltration, and chemotherapy in human pan-cancer.
    Luo N; Mei Z; Zhang Q; Tang H; Wan R; Deng A; Zou X; Lv C
    Aging (Albany NY); 2023 Dec; 15(24):15064-15083. PubMed ID: 38147024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets.
    Wu S; Zang Q; Xing Z; Li X; Leng J; Liu Y; Wang X; Yang J
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):35-48. PubMed ID: 34587434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review.
    Jiang Y; Yu J; Zhu T; Bu J; Hu Y; Liu Y; Zhu X; Gu X
    J Cancer; 2023; 14(10):1888-1903. PubMed ID: 37476189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma.
    Ma Z; Zhou Z; Zhuang H; Li Z; Ma Z; Huang B; Liu C; Gong Y; Zou Y; Zheng Z; Huang S; Zhang C; Hou B
    Dis Markers; 2021; 2021():6682697. PubMed ID: 33747255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer.
    Cipriano R; Miskimen KL; Bryson BL; Foy CR; Bartel CA; Jackson MW
    Mol Cancer Res; 2014 Aug; 12(8):1156-65. PubMed ID: 24736947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Analysis of Expression Profiles and Prognostic Significance for
    Gan J; Li Y; Meng Q
    Front Mol Biosci; 2020; 7():572406. PubMed ID: 33363204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance.
    Bartel CA; Parameswaran N; Cipriano R; Jackson MW
    Oncotarget; 2016 Aug; 7(32):52597-52612. PubMed ID: 27221039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
    Yang X; Miao Y; Wang J; Mi D
    Life Sci; 2021 May; 273():119307. PubMed ID: 33691171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-Cancer Analysis of the TRP Family, Especially TRPV4 and TRPC4, and Its Expression Correlated with Prognosis, Tumor Microenvironment, and Treatment Sensitivity.
    Chen Z; Zhao Y; Tian Y; Cao R; Shang D
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pan-Cancer Study of Epidermal Growth Factor-Like Domains 6/7/8 as Therapeutic Targets in Cancer.
    Shi S; Ma T; Xi Y
    Front Genet; 2020; 11():598743. PubMed ID: 33391349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of myeloid ecotropic viral integration site (MEIS) family genes on tumor microenvironment remodeling and its potential therapeutic effect.
    Meng L; Tian Z; Wang J; Liu X; Zhang W; Hu M; Wang M; Zhang Y
    Transl Androl Urol; 2021 Feb; 10(2):594-608. PubMed ID: 33718062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pan-cancer analysis of collagen VI family on prognosis, tumor microenvironment, and its potential therapeutic effect.
    Li X; Li Z; Gu S; Zhao X
    BMC Bioinformatics; 2022 Sep; 23(1):390. PubMed ID: 36167487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic pan-cancer analysis of the gasdermin (GSDM) family of genes and their correlation with prognosis, the tumor microenvironment, and drug sensitivity.
    Zheng Y; Yuan D; Zhang F; Tang R
    Front Genet; 2022; 13():926796. PubMed ID: 36003332
    [No Abstract]   [Full Text] [Related]  

  • 19. Pan-Cancer Analysis of OLFML2B Expression and Its Association With Prognosis and Immune Infiltration.
    Hu P; Zhang X; Li Y; Xu L; Qiu H
    Front Genet; 2022; 13():882794. PubMed ID: 35873458
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic value and immune characteristics of RUNX gene family in human cancers: a pan-cancer analysis.
    Zhao H; Chen Y; Shen P; Gong L
    Aging (Albany NY); 2022 May; 14(9):4014-4035. PubMed ID: 35522574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.